DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

H.C. Wainwright Reiterates Buy on Coherus BioSciences, Raises Price Target to $30

H.C. Wainwright reiterates Coherus BioSciences (NASDAQ:CHRS) with a Buy and raises the price target from $29 to $30.

Benzinga · 02/28/2020 12:28

H.C. Wainwright reiterates Coherus BioSciences (NASDAQ:CHRS) with a Buy and raises the price target from $29 to $30.